• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Choosing Wisely: Insights from an MAIC and eXalt3

Opinion
Video

Panelists discuss how matching-adjusted indirect comparisons (MAIC) of ALK inhibitors and the FDA approval of ensartinib in December 2024 influence frontline treatment selection for ALK+ non–small cell lung cancer (NSCLC).

Comparative Data Analysis and Ensartinib Approval

Key Themes:

  • Matching-adjusted indirect comparisons (MAIC) of lorlatinib versus alectinib or brigatinib
  • Overview of the eXalt3 study for ensartinib
  • Implications of ensartinib’s December 2024 FDA approval

Notable Insights:

  • Dr Dietrich analyzed insights from the MAIC of lorlatinib versus other ALK inhibitors

Dr Lovly provided an overview of the eXalt3 study following ensartinib’s recent FDA approval in December 2024

Related Videos
2 experts in this video
2 experts in this video
Drs Yelena Janjigian and Zev Wainberg | Background image credit: ipopba - stock.adobe.com
5 experts in this video
Antonio Urbina, MD
4 experts are featured in this series.
4 Experts are featured in this series
4 Experts are featured in this series
Related Content
BRCA1/2 gene test | Image Credit: luchschenF - stock.adobe.com

Hereditary Ovarian Cancer Genes Found Beyond Traditionally High-Risk Groups

December 4th 2025
Article

Hereditary ovarian cancer genes occur across diverse populations, supporting inclusive genetic testing.

Read More

Managed Care Cast Square thumbnail

Managed Care Cast Presents: New Evidence and Economic Considerations in IPF Care

November 25th 2025
Podcast

Experts discuss the clinical and economic burden of idiopathic pulmonary fibrosis (IPF), emerging clinical data, and strategies to improve patient outcomes.

Listen

ACIP Delays the HepB vaccine schedule as safety debates and policy tensions escalate. | Image Credit: @didesign-AdobeStock.jpeg

ACIP Delayed Hepatitis B Vaccine Schedule Vote Amid Safety Controversy

December 4th 2025
Article

ACIP delayed the vote on the hepatitis B vaccine schedule amid ongoing controversy and misinformation surrounding vaccine safety and infant immunization.

Read More

Inside the Discovery That Changed CML Treatment Forever: Jorge Cortes, MD

Inside the Discovery That Changed CML Treatment Forever: Jorge Cortes, MD

November 11th 2025
Podcast

Lead CML researcher discusses the evolution of a groundbreaking treatment and its effect on patient survival.

Listen

Patients and dermatologists found polarized dermatoscopes easier to use and producing higher-quality images, but their higher cost may limit broader adoption in teledermoscopy. | Image credit: wavebreak3 - stock.adobe.com.jpg

Polarized Dermatoscopes Improve Teledermoscopy Image Quality but Raise Cost Barriers

December 4th 2025
Article

Polarized dermatoscopes produced higher-quality teledermatology images but at greater cost, raising questions about feasibility and equitable access.

Read More

New insights on the effectiveness of guideline-recommended HF therapies in Chagas disease. | Image credit: appledesign - stock.adobe.com

Heart Failure Therapies Show Limited Impact in Chagas Disease

December 3rd 2025
Article

Guideline-recommended HF therapies do not improve major outcomes in Chagas disease, though sacubitril/valsartan improved NT-proBNP levels, new data show.

Read More

© 2025 MJH Life Sciences
AJMC®
All rights reserved.